The level of RIPK3 expression is increased in lung tissue from IPF patients. ROS production by BLM triggers RIPK3-dependent necroptosis, which takes part in fibrosis development through inflammatory cell accumulation via the release of DAMPs. Here, RIPK3 is linked to idiopathic pulmonary fibrosis.